华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301267 华厦眼科

已收盘 07-03 15:00:00

{"stockData":{"symbol":"301267","market":"SZ","secType":"STK","nameCN":"华厦眼科","latestPrice":15.14,"timestamp":1783062183000,"preClose":14.86,"halted":0,"volume":4720425,"delay":0,"changeRate":0.0188,"floatShares":648000000,"shares":840000000,"eps":0.5508,"marketStatus":"已收盘","change":0.28,"latestTime":"07-03 15:00:00","open":14.9,"high":15.21,"low":14.85,"amount":71020700,"amplitude":0.0242,"askPrice":15.14,"askSize":80,"bidPrice":15.13,"bidSize":110,"shortable":0,"etf":0,"ttmEps":0.5508,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"adjPreClose":14.86,"symbolType":"stock","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":16.35,"lowLimit":13.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":840000000,"isCdr":false,"pbRate":2.32,"roa":"--","peRate":27.487291,"roe":"3.15%","epsLYR":0.53,"committee":-0.131136,"marketValue":12718000000,"turnoverRate":0.0073,"status":0,"floatMarketCap":9817000000},"requestUrl":"/m/hq/s/301267/tweets","defaultTab":"tweets","newsList":[{"id":"2648659840","title":"华厦眼科：在高度近视、难治性青光眼、圆锥角膜、干眼诊疗、糖尿病视网膜病变等前沿领域均取得了系统性突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2648659840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648659840?lang=zh_cn&edition=full","pubTime":"2026-07-03 15:06","pubTimestamp":1783062377,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科07月03日在投资者关系平台上答复投资者关心的问题。目前公司相关科研成果转化及智能技术应用尚在逐步探索和落地中，存在不确定性，对公司业绩不构成重大影响，敬请投资者注意投资风险。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300022201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648810658","title":"华厦眼科：积极通过多渠道开展沟通交流传递公司价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2648810658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648810658?lang=zh_cn&edition=full","pubTime":"2026-07-03 11:36","pubTimestamp":1783049782,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科07月02日在投资者关系平台上答复投资者关心的问题。公司始终密切关注资本市场动态，高度重视股东权益，积极通过组织召开业绩交流会、现场集中调研、接待投资者来访、参加券商投资策略会、线上线下反路演等多渠道、多形式，开展广泛的沟通交流，传递公司价值，听取投资者对公司发展的意见及建议。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300018182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647713320","title":"华厦眼科（301267）披露2025年年度权益分派实施公告，6月29日股价上涨3.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647713320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647713320?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:53","pubTimestamp":1782726832,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，华厦眼科报收于15.53元，较前一交易日上涨3.88%，最新总市值为130.45亿元。该股当日开盘15.03元，最高15.63元，最低14.68元，成交额达8226.14万元，换手率为0.83%。近日，公司发布《2025年年度权益分派实施公告》。本次权益分派股权登记日为2026年7月2日，除权除息日为2026年7月3日。公司回购专用证券账户中的股份不参与本次权益分派。现金红利由公司委托中国结算深圳分公司代派，部分股东由公司自行派发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643223860","title":"【私募调研记录】富安基金调研华厦眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2643223860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643223860?lang=zh_cn&edition=full","pubTime":"2026-06-15 08:01","pubTimestamp":1781481685,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月12日披露的机构调研信息，知名私募富安基金近期对1家上市公司进行了调研，相关名单如下：1）华厦眼科 （富安基金参与公司特定对象调研&现场参观）个股亮点：公司积极推进大数据、人工智能等新一代信息技术的应用，加速构建智慧医疗体系，持续提升诊疗服务水平。；公司已与部分智能眼镜生产企业合作，开展智能眼镜验配，进一步挖掘智能眼镜在眼科医疗服务领域的应用潜力。目前相关业务尚在逐步探索和落地中，对公司业绩不构成重大影响以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026061500000309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642266880","title":"华厦眼科涨5.68%，东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2642266880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642266880?lang=zh_cn&edition=full","pubTime":"2026-06-12 16:39","pubTimestamp":1781253576,"startTime":"0","endTime":"0","summary":"今日华厦眼科（301267）涨5.68%，收盘报16.57元。2026年4月29日，东吴证券研究员朱国广,冉胜男,苏丰发布了对华厦眼科的研报《2025年报&2026年一季度点评：26Q1业绩回暖，屈光业务引领增长》，该研报对华厦眼科给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为56.28%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为西部证券的吕晔。华厦眼科（301267）个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200025659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639660773","title":"东海证券：给予华厦眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2639660773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639660773?lang=zh_cn&edition=full","pubTime":"2026-05-31 14:35","pubTimestamp":1780209315,"startTime":"0","endTime":"0","summary":"东海证券杜永宏近期对华厦眼科进行研究并发布了研究报告《公司简评报告：业绩稳健增长，诊疗术式持续提升》，给予华厦眼科买入评级。报告期内，公司业绩整27.07%体稳健增长，盈利能力逐渐提升。　　消费眼科增长良好，白内障业务降幅收窄。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为23.87。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100003473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638536778","title":"华厦眼科涨5.68%，东吴证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2638536778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638536778?lang=zh_cn&edition=full","pubTime":"2026-05-25 16:44","pubTimestamp":1779698689,"startTime":"0","endTime":"0","summary":"今日华厦眼科（301267）涨5.68%，收盘报17.85元。2026年4月29日，东吴证券研究员朱国广,冉胜男,苏丰发布了对华厦眼科的研报《2025年报&2026年一季度点评：26Q1业绩回暖，屈光业务引领增长》，该研报对华厦眼科给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为56.28%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为西部证券的吕晔。华厦眼科（301267）个股概况：以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500023023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636843120","title":"华厦眼科（301267）披露2025年年度股东会决议公告，5月20日股价下跌0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636843120","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636843120?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:08","pubTimestamp":1779271700,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，华厦眼科报收于16.44元，较前一交易日下跌0.84%，最新总市值为138.1亿元。该股当日开盘16.57元，最高16.57元，最低16.2元，成交额达7715.77万元，换手率为0.73%。出席会议股东代表股份占总股本的81.0393%，所有议案均获通过。上海市锦天城律师事务所对会议进行了见证并出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608730","title":"每周股票复盘：华厦眼科（301267）Q1净利增14.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608730","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608730?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:44","pubTimestamp":1777769050,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，华厦眼科报收于18.19元，较上周的18.14元上涨0.28%。本周，华厦眼科4月28日盘中最高价报18.75元。本周关注点来自业绩披露要点：2026年一季度归母净利润1.72亿元，同比上升14.69%。股本股东变化截至2026年3月31日，华厦眼科股东户数为2.13万户，较2025年12月31日减少1008.0户，减幅4.52%。户均持股数量由3.77万股增至3.95万股，户均持股市值为66.57万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631666510","title":"东吴证券：给予华厦眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631666510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631666510?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:43","pubTimestamp":1777470182,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,冉胜男,苏丰近期对华厦眼科进行研究并发布了研究报告《2025年报&2026年一季度点评：26Q1业绩回暖，屈光业务引领增长》，给予华厦眼科买入评级。2025年，公司通过非同一控制下企业合并新增了北京华厦民众眼科医院、宁波鄞州华厦眼科诊所、杭州临平华厦视光诊所等机构，持续扩大服务网络。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家；过去90天内机构目标均价为23.87。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900066929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","601555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545565","title":"华厦眼科2025年平稳双增、2026Q1盈利提速：技术+区域协同构筑长期护城河","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545565","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631545565?lang=zh_cn&edition=full","pubTime":"2026-04-29 10:57","pubTimestamp":1777431429,"startTime":"0","endTime":"0","summary":"中国网财经4月29日讯 4月27日晚间，华厦眼科 同步披露2025年年报与2026年一季报。数据显示，2025年公司实现营业收入41.39亿元，同比增长2.78%；归母净利润4.41亿元，同比增长2.80%。迈入2026年一季度，经营质量进一步改善，当期实现营收11.50亿元，同比增长5.22%；归母净利润1.72亿元，同比增长14.69%，利润增速大幅跑赢营收增速。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260429/32188038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630949311","title":"图解华厦眼科年报：第四季度单季净利润同比下降9.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630949311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630949311?lang=zh_cn&edition=full","pubTime":"2026-04-28 02:18","pubTimestamp":1777313917,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科2025年年报显示，当年度公司主营收入41.39亿元，同比上升2.79%；归母净利润4.41亿元，同比上升2.8%；扣非净利润4.25亿元，同比上升4.07%；其中2025年第四季度，公司单季度主营收入8.67亿元，同比上升2.63%；单季度归母净利润700.81万元，同比下降9.91%；单季度扣非净利润199.06万元，同比上升125.59%；负债率27.83%，投资收益4659.74万元，财务费用4748.28万元，毛利率43.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800006274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627449910","title":"华厦眼科：持续与多家保险公司开展深度沟通和合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2627449910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627449910?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:52","pubTimestamp":1776171139,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科04月13日在投资者关系平台上答复投资者关心的问题。目前，公司正沿着“医险协同、服务患者”的方向稳步推进各项工作。首先是持续与多家保险公司开展深度沟通和合作；其次在理赔服务升级上，我们已联合部分保险公司落地快赔、直赔服务。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400036393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622025009","title":"华厦眼科：截至目前公司未收到进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2622025009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622025009?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:36","pubTimestamp":1774427776,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月25日在投资者关系平台上答复投资者关心的问题。请问目前案件处于何种司法阶段？请明确回复相关情况，感谢华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。关于董事长的最新情况，截至目前公司未收到进一步通知。如有相关进展，公司定将严格按照相关法律法规的规定及时履行信息披露义务。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500030899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620446285","title":"华厦眼科：积极推进眼科医疗服务创新与智慧医疗体系建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620446285?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:07","pubTimestamp":1773731237,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月17日在投资者关系平台上答复投资者关心的问题。未来是否会拓展智慧眼科新场景？公司始终关注并积极推进眼科医疗服务创新与智慧医疗体系建设，为患者提供优质、多元化的诊疗服务。目前相关应用尚在逐步探索和落地中，对公司业绩不构成重大影响，敬请投资者注意投资风险。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700020426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617509637","title":"华厦眼科：公司将积极谋求战略新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2617509637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617509637?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:33","pubTimestamp":1772767985,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月05日在投资者关系平台上答复投资者关心的问题。公司始终密切关注资本市场动态，高度重视股东权益。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600015559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603603126","title":"华厦眼科（301267）披露董事会换届选举结果，1月15日股价上涨0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603126?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:40","pubTimestamp":1768470044,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，华厦眼科报收于19.39元，较前一交易日上涨0.05%，最新总市值为162.88亿元。该股当日开盘19.25元，最高19.58元，最低19.18元，成交额达1.15亿元，换手率为0.92%。近日，华厦眼科医院集团股份有限公司发布2026年第一次临时股东会决议公告，公司于2026年1月14日召开2026年第一次临时股东会，审议通过董事会换届选举议案。表决结果均获高票通过，中小股东参与积极。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500029324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601053100","title":"华厦眼科：全飞秒SMILE pro手术量突破6,000例","url":"https://stock-news.laohu8.com/highlight/detail?id=2601053100","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601053100?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:21","pubTimestamp":1767597680,"startTime":"0","endTime":"0","summary":"今年5月，公司下属厦门眼科中心、郑州华厦视光眼科医院、成都爱迪眼科医院等5家医院，作为全国首批眼科医疗机构，率先引进蔡司新一代机器人全飞秒VISUMAX 800手术设备及全飞秒SMILE pro手术技术。截至12月6日，上述首批引进设备开展的全飞秒SMILE pro手术量已突破6,000例。其中，厦门眼科中心是全国首家全飞秒SMILE pro手术量突破1000例的医院，也是全球最短时间突破2000例的单体医院。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516645761","title":"华厦眼科：有关董事长目前的最新情况，请查阅公司于2024年6月6日披露的相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2516645761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516645761?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:30","pubTimestamp":1741073438,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月04日在投资者关系平台上答复投资者关心的问题。有关董事长目前的最新情况，请查阅公司于2024年6月6日披露的相关公告。若有进一步信息，公司将及时履行信披义务。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030400020849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514406433","title":"华厦眼科收盘下跌1.22%，滚动市盈率29.67倍，总市值157.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406433","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514406433?lang=zh_cn&edition=full","pubTime":"2025-02-25 18:41","pubTimestamp":1740480063,"startTime":"0","endTime":"0","summary":"2月25日，华厦眼科今日收盘18.7元，下跌1.22%，滚动市盈率PE达到29.67倍，总市值157.08亿元。从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均48.80倍，行业中值45.66倍，华厦眼科排名第21位。截至2024年三季报，共有2家机构持仓华厦眼科，其中基金2家，合计持股数4.21万股，持股市值0.01亿元。华厦眼科医院集团股份有限公司主营业务为眼科医疗服务，向眼科疾病患者提供各种眼科疾病的诊断、治疗等眼科医疗服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/25184148377123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783114913782,"stockEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":-0.1008},{"period":"3month","weight":-0.0809},{"period":"6month","weight":-0.1483},{"period":"1year","weight":-0.1892},{"period":"ytd","weight":-0.1483}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0421},{"period":"6month","weight":0.0188},{"period":"1year","weight":0.1683},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华厦眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"21273人(较上一季度减少4.52%)","perCapita":"30482股","listingDate":"2022-11-07","address":"福建省厦门市湖里区五通西路999号之1701","registeredCapital":"84000万元","survey":"　　华厦眼科医院集团股份有限公司的主营业务是眼科专科医疗服务。公司的主要产品是白内障项目、眼后段项目、屈光项目、眼视光综合项目。","listedPrice":50.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华厦眼科,301267,华厦眼科股票,华厦眼科股票老虎,华厦眼科股票老虎国际,华厦眼科行情,华厦眼科股票行情,华厦眼科股价,华厦眼科股市,华厦眼科股票价格,华厦眼科股票交易,华厦眼科股票购买,华厦眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}